Skip to main content
Premium Trial:

Request an Annual Quote

ABI Stock Climbs 7.6 Percent on Positive Q3 Earnings

NEW YORK, Oct. 25 (GenomeWeb News) - Shares in Applied Biosystems were up 7.6 percent, or $1.74, at $24.55 in mid-afternoon trading after the company announced strong third quarter results today.


As GenomeWeb News reported earlier this morning, ABI had a 6.4-percent increase in revenues for its fiscal first-quarter, which ended Sept. 30, and a 55-percent jump in profits. ABI credited growth in its real-time PCR/applied genomics and mass spectrometry segments to this increase.


Despite these results, ABI President Cathy Burzik said in a statement that "we remain cautious about the growth rates in our end-user markets throughout the remainder of the fiscal year."

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.